Chiral pumping effect induced by rotating electric fields

We propose an experimental setup using 3D Dirac semimetals to access a novel phenomenon induced by the chiral anomaly. We show that the combination of a magnetic field and a circularly polarized laser induces a finite charge density with an accompanying axial current. This is because the circularly polarized laser breaks time-reversal symmetry and the Dirac point splits into two Weyl points, which results in an axial-vector field. We elucidate the appearance of the axial-vector field with the help of the Floquet theory by deriving an effective Hamiltonian for high-frequency electric fields. This anomalous charge density, i.e. the chiral pumping effect, is a phenomenon reminiscent of the chiral magnetic effect with a chiral chemical potential. We explicitly compute the pumped density and the axial-current expectation value. We also take account of coupling to the chiral magnetic effect to calculate a balanced distribution of charge and chirality in a material that behaves as a chiral battery.Comment: 6 pages, 3 figures; a new section added to discuss coupling of the CPE and the CME, a wrong sign corrected, typos fixed, elaborated for better readabilit

Statistical study of the subauroral polarization stream: Its dependence on the cross–polar cap potential and subauroral conductance

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/95602/1/jgra19576.pd

Boundary effects and gapped dispersion in rotating fermionic matter

We discuss the importance of boundary effects on fermionic matter in a rotating frame. By explicit calculations at zero temperature we show that the scalar condensate of fermion and anti-fermion cannot be modified by the rotation once the boundary condition is properly implemented. The situation is qualitatively changed at finite temperature and/or in the presence of a sufficiently strong magnetic field that supersedes the boundary effects. Therefore, to establish an interpretation of the rotation as an effective chemical potential, it is crucial to consider further environmental effects such as the finite temperature and magnetic field

Effects of intravitreal injection of ranibizumab and aflibercept for branch retinal vein occlusion on the choroid: a retrospective study

Abstract Background Macular edema is found in more than half of branch retinal vein occlusion (BRVO) cases, leading to visual loss in most of these cases. Intravitreal injection of anti-vascular endothelial growth factor is currently the standard treatment for macular edema due to BRVO (BRVO-ME). The difference in the effects of aflibercept and ranibizumab on the choroid in BRVO-ME is unknown. Therefore, we analyzed the effects of intravitreal injection of ranibizumab and aflibercept on BRVO-ME. Methods We retrospectively observed changes in choroidal thickness in the subfoveal region in 36 patients with BRVO-ME who visited the Department of Ophthalmology at the Juntendo University Urayasu Hospital. The patients were treated with intravitreal injection of aflibercept or ranibizumab and followed up for 12 months or more. Results The observed point bifurcated into the affected and non-affected sides 500 μm from the fovea. The central macular thickness (CMT) and subfoveal choroidal thickness (SFCT) were 564.2 ± 268.5 μm and 228.8 ± 50.1 μm, respectively, in the ranibizumab group (16 patients, 16 eyes) and 542.4 ± 172.5 μm and 246.1 ± 59.1 μm, respectively, in the aflibercept group (20 patients, 20 eyes). The changes in CMT at 12 months were 324.0 ± 262.6 μm and 326.55 ± 187.2 μm in the ranibizumab and aflibercept groups, respectively, with no significant difference (p = 0.97). Similarly, the changes in SFCT over 12 months were not significant between the groups (ranibizumab, 41.9 ± 33.0 μm; aflibercept, 43.8 ± 43.8 μm, p = 0.89). Conclusion The effects of ranibizumab and aflibercept on choroidal thickness in BRVO-ME were the same regardless of the site. Although BRVO is a retinal disease, we hope that we can further explore the mechanism of BRVO-ME by observing changes in the choroid in the future